Sacrom Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-07-2024
- Paid Up Capital ₹ 5.00 M
as on 07-07-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 2783.33%
(FY 2022)
- Profit 32.31%
(FY 2022)
- Ebitda 62.30%
(FY 2022)
- Net Worth -8.12%
(FY 2022)
- Total Assets -19.02%
(FY 2022)
About Sacrom Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kusum Parikh, Sachin Parikh, Roma Parikh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24246MH2007PTC168825
- Company No.
168825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2007
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sacrom Pharma Private Limited offer?
Sacrom Pharma Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments, Nutraceuticals & Dietary Supplements, Whey Protein, Hand Sanitizers & Personal Hygiene, Beauty Soap, Herbal Soaps, Surgical & ICU Equipments, Respiratory Therapy Equipment, Flavours & Aromatics.
Who are the key members and board of directors at Sacrom Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Parikh  | Director | 15-Mar-2007 | Current |
| Kusum Parikh | Additional Director | 10-Mar-2015 | Current |
| Roma Parikh | Director | 15-Mar-2007 | Current |
| Dharmendra Parikh | Additional Director | 10-Mar-2015 | Current |
Financial Performance of Sacrom Pharma.
Sacrom Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2783.33% increase. The company also saw a substantial improvement in profitability, with a 32.31% increase in profit. The company's net worth dipped by a decrease of 8.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sacrom Pharma?
In 2022, Sacrom Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Delta Agro Commodites Private LimitedActive 37 years 14 days
Kusum Parikh and Dharmendra Parikh are mutual person
- Great Equipment Leasing Co Pvt LtdActive 40 years 11 months
Kusum Parikh, Sachin Parikh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sacrom Pharma?
Unlock and access historical data on people associated with Sacrom Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sacrom Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sacrom Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
